Valérie Leroy
Investor Relations Kontakt bei VALERIO THERAPEUTICS
Profil
Valérie Leroy is currently the Director-Investor Relations & Communications at Valerio Therapeutics SA since 2016.
Prior to this, she worked as the Director-Marketing & Investor Relations at Carmat SA and as the Head-Investor Relations & Corporate Communications at Genticel SA. Ms. Leroy graduated from the Institut d'Administration des Entreprises de Paris in 1996.
Aktive Positionen von Valérie Leroy
| Unternehmen | Position | Beginn |
|---|---|---|
| VALERIO THERAPEUTICS | Investor Relations Kontakt | 01.12.2016 |
Ehemalige bekannte Positionen von Valérie Leroy
| Unternehmen | Position | Ende |
|---|---|---|
Genticel SA
 Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | Investor Relations Kontakt | - |
| CARMAT | Investor Relations Kontakt | - |
Ausbildung von Valérie Leroy
| Institut d'Administration des Entreprises de Paris | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CARMAT | Health Technology |
| VALERIO THERAPEUTICS | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genticel SA
Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | Health Technology |
